市场驱动力将切换至“盈利修复”, 自由现金流ETF(159201)近10个交易日“吸金”超7.82亿元

Core Viewpoint - The Free Cash Flow ETF (159201) has shown stability in trading, with significant inflows indicating investor confidence in the sector's future performance [1] Group 1: ETF Performance - As of January 16, at 13:40, the Free Cash Flow ETF (159201) remained flat, with constituent stocks like Yaxiang Integration hitting the daily limit up, while Weichai Power, Pinggao Electric, and Anfu Technology also saw gains [1] - Over the past 10 trading days, the largest Free Cash Flow ETF (159201) has recorded net inflows in 8 of those days, totaling over 782 million yuan [1] Group 2: Market Outlook - According to Wei Jixing, Chief Analyst at Kaiyuan Securities, the market's driving force is expected to shift from "asset revaluation" to "profit recovery" by 2026 [1] - Following the "asset revaluation" phase, a "flat top transitioning to slow upward movement" pattern is anticipated around 2026, rather than a "rapid surge followed by a drop" [1] - The "profit recovery" phase is expected to lead to a stable upward trend in the market [1]

GUANGDONG DRIVE BIO-TECH CO.-市场驱动力将切换至“盈利修复”, 自由现金流ETF(159201)近10个交易日“吸金”超7.82亿元 - Reportify